Trial NCT00785798

View at ClinicalTrials.gov 
Org. Study IDs: 0711003269

Last trial update was posted on 2022-04-04

MeSH Interventions

Doxorubicin Liposomal doxorubicin Vorinostat

MeSH Conditions

Lymphoma

Other Conditions

Refractory Lymphomas Relapsed Lymphomas

Stopping Reasons

sponsor requested

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID